DGX : Analysis & Opinions

  1. Low-risk Stock Patterns With High Reward Potential

    November 7, 2016
    These stocks present a low-risk-high-reward trading opportunity, especially if trades are placed before the stocks breakout. ...
  2. Walgreens Cuts All Ties to Blood Test Lab Theranos

    June 13, 2016
    The likelihood the government is going to bring the hammer down hard on Theranos is what's probably behind Walgreens Boots ...
  3. LabCorp's Challenges Ahead (DGX, LH)

    November 18, 2015
    LabCorp, the second largest clinical lab company, faces many challenges. Regulatory changes, reimbursement cuts, strong competition ...
  4. A Slowdown is Hitting Quest Diagnostics (DGX)

    November 13, 2015
    Quest Diagnostics holds an interesting position in the healthcare value market, but the company faces a few challenges.
  5. $9 Billion Startup Theranos Gets Disrupted

    October 16, 2015
    Theranos, a Silicon Valley startup with a $9 billion valuation, was poised to disrupt the blood testing industry. Instead, ...
  6. Bio-Reference Labs Taking Advantage Of Esoteric Opportunities

    June 22, 2012
    The decision of whether to buy Bio-Reference really comes down to an investor's confidence in the growth prospects for the ...
  7. Want A High-Yield Healthcare Stock? Look To Canada

    June 20, 2012
    CML HealthCare isn't flashy, but it's a reliable dividend payer.
  8. LabCorp Fighting Industry Headwinds

    April 24, 2012
    LabCorp is feeling pressures from large health insurers and the government, but the company remains firmly profitable and ...
Trading Center